Details of first reliable CJD test revealed

一月 15, 1999

Researchers have developed the first reliable test for new variant Creutzfeldt-Jakob disease (CJD) that can be used while the patient is still alive. Details are revealed in this week's Lancet. The test, developed under John Collinge at Imperial College, London, identifies rogue prion proteins in tonsil tissue and means doctors could test the general population.

请先注册再继续

为何要注册?

  • 注册是免费的,而且十分便捷
  • 注册成功后,您每月可免费阅读3篇文章
  • 订阅我们的邮件
注册
Please 登录 or 注册 to read this article.